2022-502969-19-00已完成1 期
A clinical trial to evaluate the absolute bioavailability and metabolic profile of aticaprant when administered as an oral tablet and a microdose intravenous infusion in healthy participants
Janssen - Cilag International, Janssen - Cilag International1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2023年9月4日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CTIS Point of Contact
Scientific
Janssen - Cilag International
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A clinical study to compare the performance of a novel solid dose injection of octreotide with a reference productAcromegalyISRCTN72107545Glide Pharmaceutical Technologies Ltd20
进行中（未招募）
不适用
Comparison of blood concentrations of tapentadol from 4 prolonged release formulations (3 granule formulations and 1 tablet formulation) in healthy adult subjects.o medical condition to be investigated.MedDRA version: 17.0Level: LLTClassification code 10049475Term: Chronic painSystem Organ Class: 100000004867EUCTR2012-005499-33-DEGrünenthal GmbH
进行中（未招募）
1 期
A Bioavailability Study of MK-3475A in Participants with Solid TumorsJPRN-jRCT2031220507Koh Yasuhiro96
进行中（未招募）
不适用
A study to compare a pediatric tablet or suspension of elvitegravir verses the adult 150 mg tablet in healthy adult volunteersHuman Immunodeficiency Virus (HIV-1) InfectionMedDRA version: 17.1Level: LLTClassification code 10020192Term: HIV-1System Organ Class: 100000004862EUCTR2015-000725-37-Outside-EU/EEAGilead Sciences, Inc.78
已完成
不适用
A study to evaluate the relative bioavailability of drug substance and formulation variants of BLZ945 and food effect in healthy participants (CBLZ945C12102)jRCT2031230272Novartis Pharma. K.K.54